Top compounds associated with response to TMEM239


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.06
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.065 0.07
mRNA Sildenafil CTRPv2 pan-cancer AAC -0.068 0.07
mRNA quizartinib CTRPv2 pan-cancer AAC -0.066 0.07
mRNA KW-2449 CTRPv2 pan-cancer AAC 0.053 0.07
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC -0.064 0.07
mRNA ibrutinib CTRPv2 pan-cancer AAC -0.074 0.07
mRNA triptolide CTRPv2 pan-cancer AAC -0.062 0.07
mRNA MI-1 CTRPv2 pan-cancer AAC -0.069 0.07
mRNA cediranib CTRPv2 pan-cancer AAC -0.093 0.07
Download CSV